Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pharmerica Corp (PMC)

Pharmerica Corp (PMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pharmerica Corp 1901 CAMPUS PLACE LOUISVILLE KY 40299 USA

www.pharmerica.com P: 502-627-7000

Description:

PharMerica Corporation is pharmacy management services provider dedicated to providing quality customer service and innovative pharmacy solutions to customers and patients in long-term care settings and in the home. PharMerica is a public company formed through the combination of the institutional pharmacy business of national healthcare services company Kindred Healthcare Inc. and pharmaceutical services company AmerisourceBergen. As a result of this combination effective, PharMerica ranks as an industry-leading U.S. provider of pharmacy management services in terms of annual revenues. Headquartered in Louisville, Kentucky, PharMerica operates approximately 103 institutional and specialty infusion pharmacies in 45 states that serve over 300,000 licensed beds for patients of long-term care facilities. PharMerica fills approximately 40 million prescriptions annually. PharMerica has approximately 6,000 employees nationwide.

Key Statistics

Overview:

Market Capitalization, $K 910,260
Shares Outstanding, K 31,120
Annual Sales, $ 2,091 M
Annual Net Income, $ 21,600 K
Last Quarter Sales, $ 595,100 K
Last Quarter Net Income, $ 3,200 K
60-Month Beta 0.83
% of Insider Shareholders 5.04%
% of Institutional Shareholders 89.97%

Growth:

1-Year Return 18.18%
3-Year Return 45.81%
5-Year Return 100.34%
5-Year Revenue Growth 0.48%
5-Year Earnings Growth 61.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.47 on 08/02/17
Latest Earnings Date 11/08/17
Earnings Per Share ttm 1.93
EPS Growth vs. Prev Qtr -2.13%
EPS Growth vs. Prev Year 4.55%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PMC Ratios

Ratio
Price/Earnings ttm 15.13
Price/Earnings forward 15.26
Price/Earnings to Growth 1.27
Return-on-Equity % 10.94%
Return-on-Assets % 4.79%
Profit Margin % 1.03%
Debt/Equity 0.84
Price/Sales 0.43
Price/Cash Flow 7.59
Price/Book 1.62
Book Value/Share 18.05
Interest Coverage 2.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar